Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Prostatic Hyperplasia × TroVax × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Carcinoma, Renal Cell 2 Prostatic Hyperplasia 1 Mesothelioma 1 Kidney Neoplasms 1 Colorectal Neoplasms 1

Interventions

mirabegron 1 TroVax 1 Radiotherapy 1 Needles 1 Electroacupuncture 1 Doxazosin 1 Docetaxel 1 Celecoxib 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01194960 2020-10-19

TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)

Oxford BioMedica

Phase 2 Terminated

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡